Peakhale SF 50 mcg/250 mcg Respicap

Peakhale SF 50 mcg/250 mcg Respicap is a respiratory medication primarily used to treat and prevent asthma and chronic obstructive pulmonary diseases (COPD) like bronchitis (inflammation of the lining of your bronchial tubes) and emphysema (shortness of breath). Asthma is a chronic (long-term) respiratory condition in which airways narrow, swell, and produce extra mucus, leading to difficulty breathing. COPD is a group of lung diseases that causes obstructed airflow from the lungs.

Peakhale SF 50 mcg/250 mcg Respicap combines two drugs: Salmeterol (bronchodilator) and Fluticasone propionate (corticosteroid). Salmeterol is a long-acting bronchodilator which works by relaxing the muscles in the airways and widening the airways. Thus, it makes breathing easier. Fluticasone propionate belongs to the class of corticosteroids that works by acting on the nasal lining's inner cells and stopping releasing certain chemicals in the body that cause inflammatory reactions. Thereby providing relief from sneezing, runny or blocked nose and sinus discomfort.

Peakhale SF 50 mcg/250 mcg Respicap is for inhalation only. Take Peakhale SF 50 mcg/250 mcg Respicap by inhaling the number of puffs as your doctor advises. Your doctor will recommend how often you take Peakhale SF 50 mcg/250 mcg Respicap based on your medical condition. Some people may experience headaches, stomach upset, dizziness, nervousness, vomiting, Respiratory tract infection, Fungal infection of the mouth, Hoarseness of voice, Sore throat, Cough, Musculoskeletal (bone, muscle or joint) pain, and Increased heart rate. Most of these side effects of Peakhale SF 50 mcg/250 mcg Respicap do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Inform your doctor if you are allergic to Peakhale SF 50 mcg/250 mcg Respicap or other ingredients. If you are pregnant or breastfeeding, please inform your doctor before using Peakhale SF 50 mcg/250 mcg Respicap. Peakhale SF 50 mcg/250 mcg Respicap is not recommended for children below 12 years of age. Use of Peakhale SF 50 mcg/250 mcg Respicap may worsen asthma symptoms in some patients. If you experience severe difficulty breathing, please consult a doctor immediately to prescribe an alternative medicine. Your doctor will prescribe a short-acting inhaler to use during attacks. If you have high blood pressure, diabetes, chest or lung infections, hyperthyroidism (overactive thyroid), hypokalaemia (low potassium levels in the blood), glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, heart, liver or adrenal gland problems, inform your doctor before taking Peakhale SF 50 mcg/250 mcg Respicap.

Peakhale SF 50 mcg/250 mcg Respicap is used to treat and prevent respiratory disorders like asthma and chronic obstructive pulmonary disease (COPD). Peakhale SF 50 mcg/250 mcg Respicap improves pulmonary function and effectively treats and prevents the worsening of emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of your bronchial tubes). Peakhale SF 50 mcg/250 mcg Respicap is a combination of two drugs: Salmeterol and Fluticasone propionate, which is used to treat asthma symptoms and chronic obstructive pulmonary disease (COPD). Salmeterol belongs to the class of bronchodilators that relax muscles and widen the lungs' airways. Thus, it makes breathing easier. Fluticasone propionate belongs to the class of corticosteroids that works by acting on the nasal lining's inner cells and stopping the release of certain chemicals in the body that cause inflammatory reactions. Thereby providing relief from sneezing, runny or blocked nose and sinus discomfort.

Please tell your doctor if you are allergic to Peakhale SF 50 mcg/250 mcg Respicap or other ingredients. If you are pregnant or breastfeeding, please inform your doctor before using Peakhale SF 50 mcg/250 mcg Respicap. Peakhale SF 50 mcg/250 mcg Respicap is not recommended for children below 12 years of age. Use of Peakhale SF 50 mcg/250 mcg Respicap may worsen asthma symptoms in some patients. If you experience severe difficulty breathing, please consult a doctor immediately so that alternative medicine may be prescribed. Contact your doctor if you have blurred vision or any other vision disturbances while taking Peakhale SF 50 mcg/250 mcg Respicap. Regular monitoring of potassium levels is recommended while taking Peakhale SF 50 mcg/250 mcg Respicap as it may cause low potassium levels in the blood. If you have high blood pressure, diabetes, chest or lungs infection, hyperthyroidism (overactive thyroid), hypokalaemia (low potassium levels in the blood), glaucoma, cataracts, osteoporosis (weak bones), tuberculosis, heart, liver or adrenal gland problems, inform your doctor before taking Peakhale SF 50 mcg/250 mcg Respicap.

• Your doctor may regularly monitor your blood potassium level as low oxygen level in the blood (hypoxia), and medicines such as Salmeterol + Fluticasone Propionate can lower blood potassium level.
• Be advised to carry an inhaler prescribed by your doctor to use in a sudden asthma attack.